Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Mollugin may help treat diseases and boost hair growth and anti-aging.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Targeting LPA could help treat skin disorders.

Loliolide from Scenedesmus deserticola may help with anti-aging.

Henna extracts effectively fight fungi.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Researchers created 10 new compounds similar to cercidin, which could lead to new antibiotics.

*Laportea bulbifera* contains unique compounds that may help treat benign prostatic hyperplasia.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

Compounds from Etlingera alba may help treat Triple Negative Breast Cancer.

Silver nanoparticles from Laurus nobilis leaves may be a new, safer antiarthritic treatment.

Lychnophora salicifolia extract in liposomes may protect skin from UV damage and inflammation.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Analog 23 is a promising compound for prostate cancer treatment.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

The process efficiently converts α-pinene oxide to campholenic aldehyde using a special catalyst, achieving high yields quickly.

A brown shadow seen in dermoscopy is a marker for lichen nitidus.

Albizia saponaria bark ethanol extract, particularly at 15%, promotes hair growth in rabbits.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.